<DOC>
	<DOC>NCT00858195</DOC>
	<brief_summary>The purpose of this study is to demonstrate the bioequivalence of Indomethacin ER Capsules.</brief_summary>
	<brief_title>A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>No clinically significant abnormal findings on physical exam, medical history or clinical laboratory results on screening Positive test results for HIV or hepatitis B or C No allergies to indomethacin or related drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Anti-inflammatory</keyword>
</DOC>